Projects per year
Personal profile
Clinical activities
Grigoriadis as the head of the myeloma service at Monash Health has been given the responsibility to expand the program and increase the profile as a clinical trials site. Prior to his commencement in that role in 2013 there were no myeloma studies at Monash Health; Grigoriadis has actively engaged with industry and been a PI on a total of 7 studies. Grigoriadis is currently a PI on 2 open Phase III myeloma studies including lenalidomide +/- pembrolizumab and pomalidomide +/- pembrolizumab in relapsed / refractory patients.
Community service
1. Leukaemia Foundation Patient Conference, Multiple Myeloma (2012, 2014, 2015)
2. Cancer Drugs Access Committee (2016-)
Research interests
Haematology
Myeloma
Myeloid malignancies
Lymphoid malignancies
Immunology
NF-kappaB
Iron
Supervision interests
Myeloma, MDS
Monash teaching commitment
HUP3011
HUP3022
MED2042
MED1011
Keywords
- Haematology
- Myeloma
- MDS
- Immunology
- NF-kappaB
- Iron
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2011 2023
Predicting response to lenalidomide based induction: Real World Experience
12/09/19 → 28/02/23
Project: Research
Augmented immune targeting of a myeloma-specific tumour antigen.
Shortt, J., Spencer, A., Reynolds, J., Johnstone, R. W., Quach, H., Grigoriadis, G., Kalff, A., Khong, T., Walker, P. A. & Powell, D.
15/12/16 → 31/12/18
Project: Research
Awakening dormant genes to help the immune system fight blood cancers
Shortt, J., Johnstone, R. W., ritchie, D., Opat, S., Grigoriadis, G., Cheah, C. Y., Dickinson, M. J., Neeson, P., Morand, E. & Banerjee, A.
1/07/14 → 30/06/18
Project: Other
The role of NF-KB transcription factor ReIA in regulatory T cell homeostasis and function
Kallies, A., Banerjee, A. & Grigoriadis, G.
National Health & Medical Research Council (NHMRC)
1/01/14 → 31/12/16
Project: Research
Research Output 1991 2019
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma
Castillo, J. J., Guerrero-Garcia, T., Baldini, F., Tchernonog, E., Cartron, G., Ninkovic, S., Cwynarski, K., Dierickx, D., Tousseyn, T., Lansigan, F., Linnik, Y., Mogollon, R., Navarro, J. T., Olszewski, A. J., Reagan, J. L., Fedele, P., Gilbertson, M., Grigoriadis, G. & Bibas, M., 1 Feb 2019, In : British Journal of Haematology. 184, 4, p. 679-682 4 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access
Concentrating non-dilute urine before protein electrophoresis for the detection of monoclonal free light chains is unnecessary and wasteful
Haran, H., Choy, K. W., Wijeratne, N., Tudball, R., Doery, J., Grigoriadis, G. & Lu, Z., 1 Aug 2018, In : Pathology. 50, 5, p. 587-588 2 p.Research output: Contribution to journal › Letter › Other › peer-review
DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma
Yuen, H. L. A., Low, M. S. Y., Fedele, P., Kalff, A., Walker, P., Bergin, K., Coutsouvelis, J., Grigoriadis, G. & Spencer, A., 5 Apr 2018, (Accepted/In press) In : Leukemia and Lymphoma. 5 p.Research output: Contribution to journal › Article › Research › peer-review
Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma
Chee, A., Low, M. S., Vilcassim, S., Gregory, G. P., Gilbertson, M., Ratnasingam, S., Grigoriadis, G. & Fedele, P. L., Sep 2018, In : British Journal of Haematology. 182, 5, p. 739-741 3 p.Research output: Contribution to journal › Article › Other › peer-review
IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos
Fedele, P. L., Willis, S. N., Liao, Y., Low, M. S., Rautela, J., Segal, D. H., Gong, J. N., Huntington, N. D., Shi, W., Huang, D. C. S., Grigoriadis, G., Tellier, J. & Nutt, S. L., 15 Nov 2018, In : Blood. 132, 20, p. 2166-2178 13 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File